Salvia BioElectronics

Despite the significant societal costs of migraine, thousands of patients in the Netherlands still do not find sufficient relief with existing therapies. Salvia BioElectronics is developing an innovative solution that could contribute to better treatment outcomes and reduced productivity loss for these patients. The investment therefore offers not only hope for patients but also social and economic added value.